Cresco Labs Inc
General ticker "CRLBF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $366.0M
Cresco Labs Inc does not follow the US Stock Market performance with the rate: -25.5%.
Estimated limits based on current volatility of 4.7%: low 0.84$, high 0.93$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.78$, 1.98$]
- 2024-12-30 to 2025-12-30 estimated range: [1.01$, 2.36$]
Financial Metrics affecting the CRLBF estimates:
- Negative: Non-GAAP EPS, $ of -0.17 <= 0.10
- Negative: Operating profit margin, % of -10.23 <= 1.03
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Positive: 7.18 < Operating cash flow per share per price, % of 11.29
- Positive: Interest expense per share, $ of 0.20 <= 0.74
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.14
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
Short-term CRLBF quotes
Long-term CRLBF plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $821.68MM | $842.68MM | $770.88MM |
| Operating Expenses | $733.71MM | $776.93MM | $858.71MM |
| Operating Income | $87.97MM | $65.75MM | $-87.82MM |
| Non-Operating Income | $-344.70MM | $-192.65MM | $-59.08MM |
| Interest Expense | $52.15MM | $58.52MM | $63.24MM |
| Income(Loss) | $-256.73MM | $-126.91MM | $-146.90MM |
| Taxes | $40.11MM | $88.94MM | $32.95MM |
| Profit(Loss) | $-296.83MM | $-215.84MM | $-179.85MM |
| Stockholders Equity | $755.55MM | $627.04MM | $505.69MM |
| Assets | $1,780.46MM | $1,583.69MM | $1,358.47MM |
| Operating Cash Flow | $14.49MM | $18.74MM | $58.56MM |
| Capital expenditure | $97.05MM | $86.13MM | $57.88MM |
| Investing Cash Flow | $-163.93MM | $-36.58MM | $-44.59MM |
| Financing Cash Flow | $235.00MM | $-86.64MM | $-26.91MM |
| Earnings Per Share* | $-1.13 | $-0.72 | $-0.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.